v3.25.2
INVESTMENTS AND FAIR VALUE MEASUREMENTS
6 Months Ended
Jun. 30, 2025
Investments And Fair Value Measurements  
INVESTMENTS AND FAIR VALUE MEASUREMENTS

3. INVESTMENTS AND FAIR VALUE MEASUREMENTS

 

The Company invests its surplus funds in excess of operational and capital requirements in a diversified portfolio of marketable securities, with the objectives of delivering competitive returns while maintaining a high degree of liquidity.

 

A summary of our short-term investments are as follows:

 

  

June 30, 2025

  

December 31, 2024

 
         
U.S. treasury securities  $3,912   $3,731 
Corporate bonds   1,213    1,182 
Short-term investments  $5,125   $4,913 

 

A summary of our long-term investments are as follows:

 

   June 30, 2025   December 31, 2024 
         
Equity securities  $563   $- 
Bifurcated embedded derivative asset   

350

    

-

 
Long-term investments  $913   $- 

 

Marketable securities

 

Marketable securities as of June 30, 2025 consisted of the following:

 

  

Cost of

Amortized

Cost

  

Unrealized

Gains

  

Unrealized

Losses

   Fair Value 
                 
Marketable debt securities                                         
U.S. treasury securities  $3,885   $27   $-   $3,912 
Corporate bonds   1,204    9    -    1,213 
Total marketable debt securities  $5,089   $36   $-   $5,125 

 

Fair Value Measurements

 

The Company’s financial instruments include cash, prepaid expenses, accounts payable, and accrued liabilities. The fair value of cash, prepaid expenses, accounts payable and accrued liabilities approximate their carrying values due to their short-term nature, which are all considered Level 1.

 

The Company’s financial instruments measured at fair value on a recurring basis consisted of U.S. treasury securities and corporate bonds. U.S. treasury securities are classified within Level 1 of the fair value hierarchy as they are valued based on quoted market price in an active market. Corporate bonds are valued based on quoted prices in markets that are less active and are generally classified within Level 2 of the fair value hierarchy.

 

The Company’s financial instruments include investment in equity securities and contingent consideration which are valued based on unobservable inputs which reflect the reporting entity’s own assumptions or data that market participants would use in valuing an instrument are generally classified within Level 3 of the fair value hierarchy.

 

Valuation Techniques

 

Bifurcated Embedded Derivative Assets

 

Bifurcated embedded derivatives are initially recorded at fair value and are then revalued at each reporting date. The fair value of the embedded derivative was calculated using a with and without method at issuance and revalued at the end of the reporting period using a Monte Carlo simulation model that used various assumptions related to term of the underlying agreement, equity value of the issuer, expected volatility, risk-free interest rate, credit risk adjusted rate, and the probability, timing, size of the future qualified financing or non-qualified financing rounds. Because the embedded conversion features are initially and subsequently carried at fair values, the Company’s condensed consolidated statements of operations will reflect the volatility in these estimate and assumption changes. The bifurcated embedded derivative net asset was $350 as of June 30, 2025. Refer to Note 5 – Convertible Notes Receivable for further details.

 

Contingent Consideration

 

Contingent consideration relates to the earnout payment set forth in the Stock Purchase Agreement governing the acquisition of Lyvecom, Inc., which provided that the selling shareholders of Lyvecom, Inc. could receive up to an additional $3,000 in cash over a 24-month earn-out period based on Lyvecom’s achievement of various performance metrics. We classified contingent consideration within level 3 of the fair value hierarchy because the fair value is derived using significant unobservable inputs, which include revenue risk premium and revenue volatility and was valued at $600. See Note 14 – Acquisition for further details of this acquisition.

 

 

Financial instruments measured at fair value on a recurring basis as of June 30, 2025 are classified based on the valuation technique in the table below:

 

Fair Value Measurements Using

 

  

Quoted Prices

in Active

Markets

for

Identical Assets

(Level 1)

  

Significant

Other

Observable

Inputs

(Level 2)

  

Significant

Unobservable

Inputs (Level 3)

   Total 
                 
Marketable debt securities                    
U.S. treasury securities  $3,912   $-   $-   $3,912 
Corporate bonds   -    1,213    -    1,213 
Total marketable debt securities  $3,912   $1,213   $-   $5,125 
Non-marketable equity securities                                
Non-marketable equity securities   $ -     $ -     $ 563     $ 563  
Total non-marketable equity securities   $ -     $ -     $ 563     $ 563  
Derivative assets                                
Bifurcated embedded derivative asset   $

-

    $

-

    $

350

    $

350

 
Total derivative assets   $

-

    $

-

    $

350

    $

350

 
Derivative liability                    
Contingent consideration  $-   $-   $(600)  $(600)
Total derivative liabilities  $-   $-   $(600)  $(600)